The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
The Hydropothecary Corporation released its financial results for their fourth quarter and fiscal year, which ended on July 31.
The Hydropothecary Corporation (TSXV:THCX) released its financial results for their fourth quarter and fiscal year, which ended on July 31.
As quoted in the press release:
“As Hydropothecary enters the next stage of its journey working towards becoming a great cannabis brand, we want our shareholders to know that we will remain focused on execution, quality and cost control. Moving forward, I also want to underscore our commitment to safe, responsible cannabis use. At Hydropothecary, we are conscious that with great opportunity also comes great responsibility,” said Sebastien St-Louis, CEO.
The Company is pleased to report revenue of $4.1M for the fiscal year ended July 31, 2017 compared with $1.9M for the fiscal year ended July 31, 2016. The Company reported a decrease in revenue from $1.2M for the third quarter of fiscal 2017 to $862K for the fourth quarter of fiscal 2017 as the result of a 14 day stop sale.
Click here to read the full press release.
Source: www.marketwired.com
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.